Novavax is a global biotechnology company with a proven vaccine technology. We’re focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health. With a strong scientific foundation, our technology includes both our recombinant protein-based nanoparticle and Matrix-M adjuvant.
Trade NOVAVAX on the XRP Ledger DEX at XRPL.to — sub-cent fees, 3-5 second settlement, no sign-up required.
Frequently Asked Questions about NOVAVAX
What is NOVAVAX?
NOVAVAX is a token issued on the XRP Ledger, listed 465 days ago. It has 4 holders and 10 trustlines. You can trade it on the XRP Ledger DEX with sub-cent fees and 3-5 second settlement.
Where can I buy NOVAVAX?
You can buy NOVAVAX directly on the XRP Ledger DEX through XRPL.to. Connect any XRPL wallet (Xaman, Crossmark, Gem Wallet) and swap XRP for NOVAVAX in one click — no centralized exchange or KYC required. The swap settles in 3-5 seconds.
What is the current price of NOVAVAX?
NOVAVAX is currently trading at 0.0000010709 XRP (+0.00% change in the last 24 hours). Live prices update every few seconds on XRPL.to as trades execute on the XRP Ledger DEX.
Is NOVAVAX verified on XRPL?
NOVAVAX has not yet been verified on XRPL.to. Always check the issuer address, holder count, and trading volume before buying any XRPL token. The issuer address for NOVAVAX is rKWa1JYg6VoZiLovd1hpai19CPaqdfEaXm.
How do I add a trustline for NOVAVAX?
To hold NOVAVAX, you need to set a trustline to the issuer (rKWa1JYg6VoZiLovd1hpai19CPaqdfEaXm) for the currency code 4E4F564156415800000000000000000000000000. Most XRPL wallets do this automatically when you initiate a swap on XRPL.to — no manual setup required. The trustline reserves 0.2 XRP, which is recoverable when you remove the trustline.
Novavax is a global biotechnology company with a proven vaccine technology. We’re focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health. With a strong scientific foundation, our technology includes both our recombinant protein-based nanoparticle and Matrix-M adjuvant.
